IA2030 Scorecard
—Global
Type to select a Country
Impact Goal 2: Promote Equity
2.2
Provide access to all vaccines
Introduction of new or underutilized vaccines in low- and middle-income countries—Global
200
150
100
50
0
166
2021
59
2022
36
2023
47
2024
2030 Target
Average of 50 annual introductions
Target: At least
500
cumulative vaccine introductions in low- and middle-income countries by 2030
On track toward 2030 target
Summary Table
| Vaccine introductions | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Total | 166 | 59 | 36 | 47 |
| Covid | 122 | 0 | 0 | 0 |
| DTP Booster 1 | 1 | 2 | 1 | 1 |
| DTP Booster 2 | 0 | 4 | 0 | 1 |
| DTP Booster 3 | 1 | 4 | 0 | 0 |
| HPV | 5 | 11 | 7 | 6 |
| Hep A | 0 | 0 | 2 | 0 |
| HepB BD | 0 | 2 | 1 | 0 |
| IPV2 | 20 | 18 | 14 | 10 |
| Influenza | 1 | 1 | 1 | 3 |
| MCV2 | 3 | 6 | 2 | 1 |
| Malaria | 0 | 0 | 0 | 14 |
| MenA | 1 | 2 | 1 | 0 |
| Mumps | 0 | 0 | 1 | 0 |
| PCV | 5 | 3 | 2 | 4 |
| Rotavirus | 4 | 1 | 2 | 2 |
| Rubella | 0 | 2 | 0 | 3 |
| Typhoid | 2 | 2 | 1 | 1 |
| Varicella | 0 | 0 | 1 | 1 |
| Yellow Fever | 1 | 1 | 0 | 0 |
The metadata for this indicator can be viewed here. The metadata typically includes the indicator's definitions, method of estimation, limitations, and sources.
Accessed: undefined
